The objective of this order is to obtain contractor project management support for cber review management project managers, task leads and management staff in their efforts to achieve cber?s strategic…
Ended Awarded Last action
- Contract number
- 75F40120F19127
- Awardee
-
Brillient Corporation UEI MMAVC7UGLJ78
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $695,548
Award facts
- Contract value 100% obligated
- $695,548.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541611 Administrative Management and General Management Consulting Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Silver Spring, MD 20993, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$111,226 | |
| Original award | $806,774 |
About this award
The Department of Health and Human Services' Food and Drug Administration awarded a $695,548 firm fixed price blanket purchase agreement call contract to Brillient Corporation, doing business as Brillient Corp, to provide project management support services to the Center for Biologics Evaluation and Research. Under the one year agreement, Brillient will assist CBER review management with project managers, task leads and management staff in achieving the agency's strategic and operational objectives. The contract was awarded against Brillient's Professional Services Schedule contract vehicle and will be performed in Silver Spring, Maryland through July 2021 to support CBER's regulatory review programs.
Description
The objective of this order is to obtain contractor project management support for cber review management project managers, task leads and management staff in their efforts to achieve cber?s strategic and operational objectives. FDA cber seeks to OBT
Quick answers
Who was awarded contract 75F40120F19127?
75F40120F19127 was awarded to Brillient Corporation by Food and Drug Administration (Department of Health and Human Services) on June 25, 2020.
How much is contract 75F40120F19127 worth?
The government has obligated $695,548 on 75F40120F19127.
Is contract 75F40120F19127 an order under another contract?
Yes. 75F40120F19127 is a BPA call under GS00F012BA-HHSF223201810005B, a blanket purchase agreement, on The Professional Services Schedule (PSS).
Was contract 75F40120F19127 competed?
The extent of competition for 75F40120F19127 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award